55KRC: UC launches new stroke study
Simply Medicine program highlights clinical trial utilizing mobile stroke units
Researchers at the University of Cincinnati are leading a clinical trial in an effort to find the first proven treatment for stroke due to intracerebral hemorrhage, when blood vessels in the brain rupture and cause bleeding in the brain.
Joseph Broderick, MD, professor in UC’s Department of Neurology and Rehabilitation Medicine in the College of Medicine, director of the UC Gardner Neuroscience Institute and a UC Health physician, is the contact principal investigator for the FASTEST study and spoke with Angenette Levy of 55KRC about it on the weekly radio show and podcast Simply Medicine.
Broderick explained time is of the essence with stroke, so the trial will utilize mobile stroke units to deliver a clotting drug to help "plug the leak" of a brain bleed within two hours of symptoms.
Listen to the Simply Medicine segment. (Note: Segment begins around 30:51 mark.)
Featured photo at top of Dr. Broderick. Photo/Joseph Fuqua II/University of Cincinnati
Related Stories
UC Cancer Center taps new director
February 11, 2026
The Cincinnati Business Courier spoke with David Gius, MD, PhD, who was recently named the next director of the University of Cincinnati Cancer Center.
UC researcher adds Chicago collaboration
February 11, 2026
University of Cincinnati research examining how public art and murals influence foot traffic, neighborhood vitality and economic development is now shaping planning conversations well beyond Cincinnati.
UC trial tests new nonpharmacological treatments for depression
February 11, 2026
The University of Cincinnati’s Fabiano Nery, MD, PhD, has received a five-year, approximately $3.5 million grant from the National Institutes of Health’s National Center for Complementary and Integrative Health to launch a clinical trial testing two new nonpharmacological treatments for teens and young adults with depression.